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Abstract
Background: A physiological increase in extracellular ascorbate (AA), an antioxidant vitamin
found throughout the striatum, elevates extracellular glutamate (GLU). To determine the role of
behavioral arousal in this interaction, microdialysis was used to measure striatal GLU efflux in rats
tested in either a lights-off or lights-on condition while reverse dialysis either maintained the
concentration of AA at 250 µM or increased it to 1000 µM to approximate endogenous changes.
Results: When lights were off, both locomotion and GLU increased regardless of AA dose. In
contrast, animals in the lights-on condition were behaviorally inactive, and infusion of 1000, but not
250, µM AA significantly increased extracellular GLU. Interestingly, when ambient light returned to
the lights-off group, 1000 µM prolonged the GLU increase relative to the 250 µM group.
Conclusion:  Our results not only support evidence that elevated striatal AA increases
extracellular GLU but also indicate that this effect depends on behavioral state and the
corresponding level of endogenous GLU release.
Background
Accumulating evidence indicates that ascorbate (AA), an
antioxidant vitamin, plays a critical role in modulating
striatal function. An increase in extracellular AA, for exam-
ple, enhances corticostriatal glutamate (GLU) transmis-
sion [1,2] as well as the response of striatal neurons to
GLU iontophoresis [3,4]. Under naturally occurring con-
ditions, striatal AA release rises and falls, respectively, with
increases and decreases in the level of behavioral activity
[5,6]. Extracellular GLU [7] and striatal neuron firing rate,
which depends on GLU input [8], follow a similar behav-
ior-related pattern. To assess the extent to which the level
of behavioral activity influences the ability of AA to mod-
ulate extracellular GLU in striatum, we used microdialysis
to elevate AA and measure GLU efflux in rats tested under
different behavioral conditions. All animals were tested at
the same time of day, the onset of the nocturnal phase of
the circadian cycle, but AA effects were tested either with
the lights on, which suppresses behavioral activity, or
lights off, which causes behavioral activation.
Results
During the baseline period when lights were on, all rats
rested quietly and tended to remain in a single corner of
the open field. All six rats exposed to continuous light
(lights-on) showed minimal to no ambulation through-
out the session. In contrast, the six exposed to darkness
(lights-off) during the experimental period showed spon-
taneous locomotion as well as rearing and exploratory
sniffing, and this activity persisted, albeit at a lower level,
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even as ambient light returned in the post-experimental
period. Fig. 1 depicts this darkness-induced behavior
increase for quadrant crosses. These animals crossed more
quadrants than those in the lights-on group during both
the experimental [t(11) = -3.53, p < 0.01] and post-exper-
imental [t(11) = -3.02, p = 0.01] periods. While it was
expected that returning ambient light (post-experimental)
following darkness exposure would result in more imme-
diate behavioral cessation, their decreased locomotion
was not significant [t(11) = 2.047, p = 0.065]. Quadrant
crosses were unaffected by reverse dialysis of either 250 or
1000 µM AA [p > 0.05 in both cases] ruling out an effect
of AA alone on locomotion.
Like quadrant crossings, GLU increased dramatically
when lights were off regardless of treatment (Fig. 2A,B).
Relative to the lights-on group, which remained behavio-
rally inactive, lights off triggered a GLU response that
increased steadily throughout the experimental period. A
repeated-measures ANOVA revealed a significant increase
in GLU during either the first 45 min (dashed box) or the
entire 75 min (solid box) of the experimental period for
both the 250 µM [F(3,30) = 8.95, p < 0.01 and F(5,50) =
6.756, p < 0.01, respectively] and 1000 µM AA infusion
[F(3,30)= 9.00, p < 0.01 and F(5,50) = 11.41, p < 0.01,
respectively] among dark/active relative to lights-on/inac-
tive animals. Interestingly, when the post-experimental
(lights back on) collections were included in the analysis,
the GLU increase continued for the dark-exposed animals
treated with 1000 µM AA (Fig. 2B) [F(7,70) = 6.50, p <
0.01], but not 250 µM AA (Fig. 2A) [F(7,70) = 2.07, p =
0.06], suggesting that elevated AA can prolong the behav-
ior-related GLU response. In fact, the mean (± SEM) per-
cent GLU increase above baseline for the final post-
experimental collection was 314.10 ± 73.10 for the 1000
µM infusion and 152.40 ± 55.90 for the 250 µM group.
Thus, not only does behavioral activity increase GLU, but
a high concentration of AA can extend this effect.
Analyzing the GLU response by AA treatment (Fig. 2C,D)
revealed an effect of 1000 µM during the experimental
period but only for the lights-on condition and only dur-
ing the early phase of this period. Thus, there was a signif-
icant effect of AA treatment during the first 45 min
(dashed box) [F(3,15) = 3.83, p = 0.03], but not the entire
75 min (solid box) [F(5,25) = 1.81, p = 0.15] of the lights-
on condition (Fig. 2C). No AA difference emerged for the
lights-off condition (Fig. 2D) at either time [45 min:
F(3,15) = 2.73, p = 0.08; 75 min: F(5,25) = 2.29, p = 0.08].
Thus, a darkness-induced behavioral activation appeared
to elevate GLU to a level that obscured the AA effect evi-
dent in behaviorally inactive animals. Extending our anal-
ysis through the post-experimental period revealed no
significant AA dose effect for either the lights-off (Fig. 2D)
[F(7,35) = 2.06, p = 0.08] or the lights-on group (Fig. 2C)
[F(7,35) = 1.15, p = 0.36].
Discussion
Our results indicate that although an increase in AA can
elevate GLU in striatal extracellular fluid, this effect is sen-
sitive to behavioral state. Reverse dialysis of 1000 µM AA
increased extracellular GLU during the lights-on condi-
tion, when rats rested quietly, but failed to alter the
increase in GLU during lights-off when maximal behavio-
ral activity occurred. Thus, the AA-induced potentiation of
the magnitude of the GLU response appears limited to
behaviorally quiet or less-active conditions when endog-
enous GLU release is relatively low. There is growing sup-
port for increases in GLU release correlating with general
Locomotor responses to light manipulation among the two  groups of animals tested: open bars indicate the group expe- riencing continuous ambient light; hatched bars indicate  those experiencing 75-mins of darkness restricted to the  experimental period Figure 1
Locomotor responses to light manipulation among the two 
groups of animals tested: open bars indicate the group expe-
riencing continuous ambient light; hatched bars indicate 
those experiencing 75-mins of darkness restricted to the 
experimental period. Mean (± SEM) quadrant crossings 
according to periods are collapsed across dialysis session in 
the main graph as AA treatment was found to have no effect 
on locomotor behavior. Status of lights is indicated by the 
upper X-axis, and the three consecutive dialysis periods by 
the lower from left to right. Note the increase in behavior 
associated with turning off lights during the experimental 
period, only among those animals that experienced lights off 
(hatched bars) that lingered when lights were turned back on 
(post period). * p < 0.02 for between-subject comparisons of 
lights-on versus darkness exposed animals (hatched versus 
open bars); † p < 0.05 for within-subjects comparisons with 
initial (lights on) baseline among darkness exposed animals 
(hatched bars only).BMC Neuroscience 2007, 8:32 http://www.biomedcentral.com/1471-2202/8/32
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GLU changes are presented as mean percent change from the median of four baseline collections (± SEM) for the dialysates  indicated on the abscissa Figure 2
GLU changes are presented as mean percent change from the median of four baseline collections (± SEM) for the dialysates 
indicated on the abscissa. A combination of 250 µM-AA CSF and "Lights ON" conditions were utilized wherever white or grey-
filled icons appear. Black-filled icons indicate when animals were either responding to darkness (A & B), treated with 1000 µM 
AA (C & D), or both (B & D). The within-subjects factor was AA-treatment, as all animals were treated with both AA levels, 
250 µM and 1000 µM AA, in separate dialysis sessions during the experimental period indicated below each graph. Separate 
graphs depict the GLU level changes occurring in response to lights-out (A & B), or AA treatment (C & D). The boxes within 
each graph depict time points where separate analyses were performed (last baseline through 45 min dashed, last baseline 
through 75 min solid). Repeated measures ANOVA analyses within the dashed boxes were significant in A, B, & C. The first 
45-min was the only period during which a significant GLU increases in response to AA treatment across collections was 
exposed, and only during the "LIGHTS ON" experiment (C). Note the large effects of darkness exposure (Experimental 
period, black-filled icons) on striatal GLU levels depicted in graphs A & B. When the two "Post" collections (black & grey-filled 
versus white-filled) were included, significant increases in GLU levels occurred across all collections (15–120 min) compared to 
baseline when animals treated with 1000 µM AA were exposed to darkness (B). However increases in GLU were only signifi-
cant during the Experimental period (15–75 min) when animals were treated with 250 µM AA (A).BMC Neuroscience 2007, 8:32 http://www.biomedcentral.com/1471-2202/8/32
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behavioral activity. Research on forced-limb use, for
example, showed that increased activity of free limbs
resulted in increased extracellular GLU in contralateral
sensorimotor cortex compared with cortex contralateral to
a casted forelimb across extended periods [13]. Regarding
discrete periods of behavior, rearing behavior in freely-
moving mice has been associated with discrete increases
in striatal GLU measured with 13-s resolution [14]. It is
possible that the relatively high GLU level during behav-
ioral activity prevented a further AA-induced increase.
When ambient light returned, dark-exposed animals were
still active but no longer at their behavioral peak. Under
these conditions, prior infusion of 1000, but not 250 µM
AA maintained the GLU increase during the post-experi-
mental period. In fact, post-experimental GLU leveled off
in the lights-off animals treated with 250 µM. Thus,
although the concentration of extracellular GLU may
approach a maximal rate of increase during robust behav-
ioral activity, AA appears to enhance this GLU effect by
allowing it to continue even as behavior declines toward
baseline. Further assessment of the AA-induced change in
the behavior-related GLU response is warranted.
The relationship between extracellular AA and GLU
appears to depend on the outward transport of AA during
GLU uptake [15-17]. Thus, a high level of extracellular AA
may prevent GLU uptake by opposing further release of
endogenous AA. In line with this prediction, the addition
of 500 to 1000 µM AA to striatal extracellular fluid signif-
icantly delayed the removal of electrically evoked GLU
release [2]. At the neuronal level, moreover, an increase in
extracellular AA significantly enhanced the absolute mag-
nitude of the excitation evoked by GLU iontophoresis –
albeit without prolonging the response [4]. It appears,
therefore, that GLU transmission is regulated, at least in
part, by the level of extracellular AA. We show here that in
awake animals an increase in extracellular AA can, in fact,
elevate striatal GLU release when animals are behaviorally
quiet. This effect is less straightforward, however, during
behavioral activation.
A likely reason for the complicating effect of behavior is
the release of endogenous AA, which, according to AA-
GLU heteroexchange [18], would normally accompany
the behavior-related increase in GLU transmission. If
endogenous extracellular AA is already sufficiently high to
interfere with GLU uptake, as would be expected during
lights-off when behavior is maximally stimulated, then
additional AA will have no further effect. In fact, striatal
extracellular AA during behavior can more than double
the resting or anesthetized level [18], which ranges
roughly between 200 and 400 µM depending on striatal
location [19]. Our use of 250 µM in control aCSF should
minimize resting AA depletion but allow for endogenous
AA release during GLU uptake. Extracellular application of
1000 µM AA blocks the uptake of electrically evoked GLU
release from corticostriatal fibers in anesthetized animals
[2] and appears to match the extracellular concentration
of endogenous AA that can be attained during naturally
occurring or drug-evoked periods of behavioral activation
[6,20]. As GLU release plateaus and behavior begins to
decline during the return of ambient light, endogenous
AA release is also likely to plateau, thus allowing for 1000
µM AA to exert a GLU effect.
Interestingly, GLU variability seemed to increase over
time (see Fig. 2). A likely source of this variability is the
rate of striatal AA perfusion during reverse dialysis.
Although animals within a group received the same AA
concentration, different AA diffusion rates between
probes may have allowed AA to affect GLU at different
times during the experimental period. This type of varia-
bility may have terminated the AA-induced increase in
GLU at 45 min in the lights-on condition (Fig. 2C). It is
unlikely that individual differences in locomotion con-
tributed to the variability since animals were consistently
inactive (lights-on) or active (lights-off) during the exper-
imental period.
Conclusion
Our results add to increasing evidence that AA modulates
GLU transmission. If, as the heteroexchange model pre-
dicts, GLU uptake requires AA release, then the rise in
extracellular GLU during behavior may result from a slow-
ing of uptake due to the progressive accumulation of
extracellular AA. Other mechanisms also may contribute,
including glutamate-cystine exchange since, like cystine,
AA is a redox molecule [23]. Although the source of GLU
measured in our experiments may include both neuronal
and metabolic pools, previous data indicate that the AA-
GLU interaction is directly relevant to neuronal release
[2]. Because dysfunctional GLU has been implicated in a
wide range of clinical conditions from drug addiction to
neurodegenerative disease [21,22], further research on an
AA-GLU link may have important therapeutic benefits.
Methods
Male Sprague-Dawley rats (~300 g) were bred from source
animals originating from Harlan Industries (Indianapolis,
IN). All animals were housed individually under standard
laboratory conditions (12-hr light cycle from 07:30 to
19:30) with free access to food and water. Protocols were
performed in compliance with the Guide for the Care and
Use of Laboratory Animals (1996), and approved by the
local Institutional Animal Care and Use Committee.
While the animals were under chloropent anesthesia
(0.33 ml/100 g ip), a 21-ga stainless steel intracerebral
guide cannula (C312G, Plastics One, Roanoke, VA) was
inserted unilaterally to the dorsal ridge of anterior stria-BMC Neuroscience 2007, 8:32 http://www.biomedcentral.com/1471-2202/8/32
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tum: 0.6 mm anterior and 2.8 mm lateral to bregma, and
3.2 mm ventral to skull surface [9]. The guide cannula was
secured to the skull with screws and dental cement; an
obturator kept the guide debris free. During a two-day
recovery period, each rat was habituated to the microdial-
ysis arena (30 × 41.5 cm with sloped sides to allow for
ease of movement) for at least an hour.
Intracerebral infusion cannulae (26-ga, C312I, Plastics
One, Roanoke, VA) were converted into concentric style
microdialysis probes with a 4.0 mm semi-permeable tip
of hollow regenerated cellulose fiber (200 µm internal
diameter, 18 kD cut off, Spectrum, Houston, TX). All
probes were tested prior to each microdialysis session for
in-vitro recovery of 75 µM GLU standards at room tem-
perature to yield average recoveries ranging between 8 and
14%. Data from probes with ≤ 5% recovery were not
included.
For all microdialysis sessions, artificial cerebrospinal fluid
(aCSF: 155.0 mM Na+, 2.9 mM K+, 1.1 mM Ca2+, 0.83 mM
Mg2+, 132.76 mM Cl-, 0.25 mM Na-l-AA, and 5.9 mM D-
glucose) was pumped through the probe at 2.0 µl/min
(see [10]). Dialysates were collected at 15-min intervals in
polyethylene autosampler vials and immediately frozen
on dry ice. Each session began at 17:00 with insertion of
the microdialysis probe followed by a two-hour discard
period. The same pattern of dialysis collections were taken
from each animal regardless of group (lights-on versus
lights off) or treatment administered during the experi-
mental period in each of two dialysis sessions (250 or
1000 µM AA). At 19:00, we collected four 15-min baseline
microdialysis samples (baseline period, always 250 µM
AA), followed by a 15-min discard period and then five
experimental samples (experimental period). During the
experimental period, rats received either the baseline aCSF
(250 µM AA, control) or aCSF containing 1000 µM AA.
Each session concluded with return to control aCSF deliv-
ered during two post-experimental collections. Note that
control aCSF included a 250 µM concentration of AA to
prevent the behavioral impairments caused by depletion
of endogenous AA in striatum [11].
Two groups containing six rats each were tested with two
different ambient light conditions that differed in whether
ambient light was on or off during the experimental
period (lights-on and lights-off groups). In the lights-on
condition, the lights remained on throughout the micro-
dialysis session. Rats in the lights-off group were always
dialyzed in the dark during the experimental period. All
rats in each condition underwent two microdialysis ses-
sions, in which control and 1000 µM AA infusions were
delivered (during the experimental period) in counterbal-
anced order, separated by an intervening day of recovery.
Control aCSF was always delivered during all other dialy-
sis periods (baseline and post-experimental sessions).
Because rats were tested twice, and second dialysis ses-
sions sometimes show decreased transmitter yield com-
pared to the first due to gliosis, a pairwise comparison was
performed on median baseline measures corrected for
recovery across both sessions for all animals. No signifi-
cance was found [t(11) = 1.709, p = 0.116], ruling out a
session effect. Environmental conditions, moreover, were
identical during baseline collections to ensure that all ani-
mals began with similar GLU levels.
Behavior (e.g., forward locomotion, grooming, rearing,
and sniffing) was observed during collection of each
microdialysis sample. Locomotor activity was quantified
by dividing the arena floor into four equal quadrants and
recording the number of quadrants entered during each
observation period; the rat's final quadrant location was
recorded to define the starting point for each collection
period beginning when a new collection vial was
attached. Cumulative quadrant entry counts were then
generated for each collection period (baseline, experimen-
tal, post-experimental). To observe behavior when lights
were off, two red bulbs (7.5 W) were illuminated: one ~60
cm above the dialysis arena, and the other on the adjacent
table for recording data.
After completion of the second dialysis session, each rat
was transcardially perfused with formosaline, and brain
slices were mounted on microscope slides for verification
of probe placement. Only data from subjects with appro-
priately placed probe-related gliosis in anterior striatum
were analyzed further. A representative section is shown
in Fig. 3.
Analysis of dialysate GLU was performed by high pressure
liquid chromatography with electrochemical detection
(ESA, Bedford, MA) in conjunction with pre-column
derivitization (as modified by Yamamoto & Davy)[12].
GLU concentrations were determined by generating a
regression curve based on titrated external standards and
then correcting for probe recovery by analyzing the in-
vitro recovery collections taken before each experiment.
GLU concentrations measured in the last baseline, and
each experimental and post-experimental sample were
expressed as a percent change from the median of the four
baseline collections and evaluated by repeated-measures
ANOVA assessed against the percent change value
obtained from the last baseline collection. Repeated
measures ANOVAs were also used to assess the effects of
ambient light and AA treatment on locomotion.
Abbreviations
AA = ascorbate
aCSF = Artifical Cerebral Spinal FluidBMC Neuroscience 2007, 8:32 http://www.biomedcentral.com/1471-2202/8/32
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ANOVA = Analysis of Variance
GLU = glutamate
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Representative microdialysis probe placement shown in a 40  µm coronal section Figure 3
Representative microdialysis probe placement shown in a 40 
µm coronal section. Wider cortex damage represents the 
intracerebral guide cannula termination, while the gliosis 
seen ventrally shows the typical terminal end of the 4.0 mm 
semipermeable microdialysis probe tip.